Dave Kappos Speaks at 2022 Global Forum on Intellectual Property

On August 8, 2022, Global Blood Therapeutics, Inc. (“GBT”), a biopharmaceutical company dedicated to the discovery, development and delivery of life‑changing treatments that provide hope to underserved patient communities, starting with sickle cell disease, and Pfizer Inc. (“Pfizer”) announced that the companies have entered into a definitive agreement under which Pfizer will acquire GBT. Under the terms of the transaction, Pfizer will acquire all the outstanding shares of GBT for $68.50 per share in cash, for a total enterprise value of approximately $5.4 billion, including debt and net of cash acquired. Cravath is representing GBT in connection with the transaction.

On June 21, 2022, Convey Health Solutions Holdings, Inc. (“Convey”), a leading healthcare technology and services company, announced that it has entered into a definitive merger agreement pursuant to which TPG Capital, the private equity platform of global alternative asset management firm TPG and Convey’s principal shareholder, will acquire all of the outstanding shares of Convey common stock not currently owned by TPG or certain management and director shareholders for $10.50 per share in cash, representing an enterprise value of approximately $1.1 billion. Cravath is representing Convey in connection with the transaction.

On June 21, 2022, Pitney Bowes, a global shipping and mailing company, and Global‑e, a cross‑border end‑to‑end platform for brands and retailers, announced they have entered into a definitive agreement for Global‑e to acquire from Pitney Bowes the Borderfree cross‑border ecommerce solutions business. In addition, the companies will begin a strategic partnership and commercial relationship whereby Pitney Bowes will provide cross‑border ecommerce logistics services to Global‑e and its clients, and Pitney Bowes’s clients will receive access to cross‑border solutions on the Global‑e platform. Cravath is representing Pitney Bowes in connection with the transaction.

On June 7, 2022, Elsevier, a global leader in research publishing and information analytics, and part of RELX, a global provider of information‑based analytics and decision tools for professional and business customers, announced it has closed the acquisition of Interfolio, a provider of advanced faculty information solutions for higher education. Interfolio will be part of Elsevier’s Research Intelligence portfolio. Cravath represented RELX in connection with the transaction.